BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 65871)

  • 21. [Prognostic value of circulating immune complexes of carcinoembryonic antigen (CEA) in patients with adenocarcinoma of the gastrointestinal tract (author's transl)].
    Staab HJ; Anderer FA; Stumpf E; Fischer R
    J Clin Chem Clin Biochem; 1980 Mar; 18(3):175-81. PubMed ID: 7381371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carcinoembryonic antigen in gastrointestinal neoplasms].
    Auer IO
    Dtsch Med Wochenschr; 1977 Jul; 102(30):1101-4. PubMed ID: 330129
    [No Abstract]   [Full Text] [Related]  

  • 23. [Carcinoembryonic antigen (CEA) in digestive tract diseases].
    Gorski M; Jabłonska-Kaszewska I; Bielawski W; Gan J; Dabrowska E; Fenc E
    Pol Tyg Lek; 1980 Jul; 35(27):1009-12. PubMed ID: 7422592
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological diagnosis and prognosis of digestive tract cancer: some clinical considerations.
    Zamcheck N
    Ann Immunol (Paris); 1973 Nov; 124(4):635-40. PubMed ID: 4792503
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [How are tumor markers used in diagnosis and in after-care of gastrointestinal cancers? Results of a nation-wide German survey].
    Fischbach W; Ritter P
    Med Klin (Munich); 1992 Nov; 87(11):576-9. PubMed ID: 1470053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

  • 28. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tissue polypeptide antigen (TPA) as a tumor marker in disorders of the digestive tract: comparison with CEA].
    Piantino P; Tappero G; Cerchier A; Pecchio F; Tridico F; Cattaneo U
    Minerva Med; 1986 Apr; 77(16):617-20. PubMed ID: 3703360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of carcinoembryonic antigen (CEA) and CEA-S assays in the evaluation of neoplasm of the gastrointestinal tract.
    Nakamura RM; Plow EF; Edgington TS
    Ann Clin Lab Sci; 1978; 8(1):4-10. PubMed ID: 623429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoembryonic antigen in patients with gastric carcinoma.
    Janssen CW; Orjasaeter H
    Eur J Surg Oncol; 1986 Mar; 12(1):19-23. PubMed ID: 3956751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic use of preoperative and immediate postoperative carcinoembryonic antigen determinations in colonic cancer.
    Oh JH; MacLean LD
    Can J Surg; 1977 Jan; 20(1):64-7. PubMed ID: 832207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical value of the plasma-CEA-concentrations for the activity control of chronic inflammatory intestinal diseases].
    Auer IO; Schmid L; Ziemer E; Sommer H; Epping J
    Z Gastroenterol Verh; 1976; (11):109-12. PubMed ID: 65852
    [No Abstract]   [Full Text] [Related]  

  • 35. [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system].
    Bianucci P; Pastorino G; De Rossi O; Brondi P
    Minerva Med; 1979 Dec; 70(54):3701-4. PubMed ID: 574929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical detection of carcinoembryonic antigen in esophageal carcinomas: a comparison with other gastrointestinal neoplasms.
    Bhatnagar J; Heroman W; Murphy M; Austin GE
    Anticancer Res; 2002; 22(3):1849-57. PubMed ID: 12168881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CEA--a concept worth exploring.
    O'Brien PH
    Am Surg; 1980 Nov; 46(11):633-6. PubMed ID: 7436141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Circulating "tumor markers" in gastrointestinal tumors].
    Borlinghaus P; Lamerz R
    Leber Magen Darm; 1991 Sep; 21(5):199-202, 205-6. PubMed ID: 1758235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
    Zamcheck N
    Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
    [No Abstract]   [Full Text] [Related]  

  • 40. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.